JBT Marel (JBTM) Reports $3.9b Revenue, Is It Still Below Fair Value?
JBT Marel (JBTM) has drawn fresh attention after reporting annual revenue of $3,880.2 million and net income of $168.3 million, putting its food and beverage technology operations in clearer focus for investors.
See our latest analysis for JBT Marel.
JBT Marel’s recent revenue and earnings update has coincided with a 22.08% 3 month share price return and a 6.57% 1 year total shareholder return, suggesting momentum has picked up after a weaker year to date share price performance.
If you are comparing JBT Marel with other trends in automation and processing technology, this could be a good moment to scan the market using our robotics and automation ideas via the 34 robotics and automation stocks.
After a strong three-month move and with JBT Marel trading below both analyst targets and some intrinsic value estimates, the gap between price and fair value looks wide enough to examine more closely next.
Most Popular Narrative: 18.5% Undervalued
With JBT Marel last closing at $145.75 against a narrative fair value of $178.75, the prevailing view is that the market is leaving some value on the table.
The ongoing global increase in protein consumption and demand for food safety/traceability is driving sustained investment in automation and integrated processing solutions, supporting a robust order backlog (notably in poultry and meat), which is likely to provide multi-year revenue growth.
Curious what sits behind that fair value gap? The narrative leans on stacked earnings growth assumptions, rising margins and a future P/E reset. The exact mix of those inputs is where things get interesting.
Result: Fair Value of $178.75 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the JBT Marel narrative also leans on successful merger integration and manageable tariff impacts, and setbacks on either front could quickly challenge that fair value gap.
Find out about the key risks to this JBT Marel narrative.
Next Steps
This mix of optimism and caution around JBT Marel will likely be resolved soon, so check the facts for yourself and decide where you stand. To see both sides laid out clearly, review the 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond JBT Marel?
If you stop with JBT Marel, you could miss other stocks that fit your goals. Use the Simply Wall Street Screener to quickly surface fresh opportunities.
- Spot potential bargains early by reviewing companies that show strong fundamentals and attractive valuations through the 49 high quality undervalued stocks.
- Strengthen your income stream by assessing companies with higher yields and consistent payouts using the 8 dividend fortresses.
- Prioritise resilience by focusing on businesses with robust finances and lower risk profiles via the 83 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com